Nature Communications (Sep 2020)

NEMF mutations that impair ribosome-associated quality control are associated with neuromuscular disease

  • Paige B. Martin,
  • Yu Kigoshi-Tansho,
  • Roger B. Sher,
  • Gianina Ravenscroft,
  • Jennifer E. Stauffer,
  • Rajesh Kumar,
  • Ryo Yonashiro,
  • Tina Müller,
  • Christopher Griffith,
  • William Allen,
  • Davut Pehlivan,
  • Tamar Harel,
  • Martin Zenker,
  • Denise Howting,
  • Denny Schanze,
  • Eissa A. Faqeih,
  • Naif A. M. Almontashiri,
  • Reza Maroofian,
  • Henry Houlden,
  • Neda Mazaheri,
  • Hamid Galehdari,
  • Ganka Douglas,
  • Jennifer E. Posey,
  • Monique Ryan,
  • James R. Lupski,
  • Nigel G. Laing,
  • Claudio A. P. Joazeiro,
  • Gregory A. Cox

DOI
https://doi.org/10.1038/s41467-020-18327-6
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 12

Abstract

Read online

Defective protein quality control is a key feature of neurodegeneration. Here, the authors show that mutations in Nemf/NEMF, a component of the Ribosome-associated Quality Control complex, have a neurodegenerative effect in mice and may underlie neuromuscular disease in seven unrelated families.